期刊文献+

三羟基异黄酮对肝纤维化大鼠血清和肝组织中TGF-β_1表达的影响 被引量:2

Effect of Genistein on TGF-β_1 in plasma and hepatic tissue of CCl_4-induced hepatic fibrosis rats
下载PDF
导出
摘要 目的观察4,5,7-三羟基异黄酮(Genistein)对四氯化碳(CCl4)诱导的肝纤维化大鼠的防治作用及对转化生长因子β1(TGF-β1)表达的影响。方法采用CCl4造成大鼠肝纤维化模型,在实验的第10周末采血和取肝组织,检测血清中ALT、AST、TGF-β1和Ⅰ型胶原,HE染色法观察肝组织改变,免疫组织化学法检测肝组织TGF-β1表达。结果血清学检测显示Genistein能明显降低肝纤维化大鼠ALT、AST、TGF-β1和Ⅰ型胶原水平,病理组织学观察发现Genistein能明显改善肝纤维化大鼠肝组织结构和肝纤维化,免疫组织化学检测表明肝组织TGF-β1表达量与模型组比较显著降低。结论 Genistein对CCl4诱导的肝纤维化大鼠有较好的保护作用,对TGF-β1表达的影响可能是其作用机制之一。 Objective To investigate the antifibrotic effect of 4,5,7-Genistein on CCl4-induced liver fibrosis in rats and expression of TGF-β1. Methods A hepatic fibrosismodel was induced by CCl4.The levels of alanine transaminase (ALT),aspartic transaminase (AST),TGF-β1 and type-Ⅰcollagen in plasma were detected by chemical kit. The deposition of collagen was observed with HE staining. The expression of TGF-β1 in hepatic tissue was observed by immuno-histochemistry. Results The concentration of serum ALT,AST,TGF-β1 and type-Ⅰcollagen was significantly reduced in the middle and high dose treated groups compared with that of model group. A significant reduction of collagen deposition and rearrangement in Genistein -treated group was displayed in histopathological changes. The expression of TGF-β1 was considerably decreased in the treated animals. Conclusion Genistein has an obvious protective effect on model rats,and remarkably inhibits TGF-β1 expression in plasma and liver tissue which is thought to be one possible antifibrogenic mechanism.
作者 廖明
机构地区 广西医科大学
出处 《中国实用医药》 2010年第15期1-3,共3页 China Practical Medicine
基金 广西地方性高发疾病防治研究重点实验室开放基金(项目编号:桂科能0842009-k5)
关键词 三羟基异黄酮 肝纤维化 TGF-Β1 Genistein Hepatic fibrosis TGF-β
  • 相关文献

参考文献11

  • 1Bataller R,Brenner DA.Liver fibrosis.J Clin Invest,2005,115(2):209-218.
  • 2Friedman SL.Liver fibrosis from bench to bedside.J Hepatol,2003,38(S1):S38-53.
  • 3Gressner AM,Weiskirchen R.Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets.J Cell Mol Med,2006,54(10):76-99.
  • 4廖明,李彦,舒伟.Genistein对大鼠肝星状细胞的增殖及TGF-β1、MMP-2和TIMP-2表达的影响[J].世界华人消化杂志,2010,18(3):229-233. 被引量:11
  • 5Giannelli G,Antonaci S.Immunological and molecular aspects of liver fibrosis in chronic hepatitis C virus infection.Histol Histopathol,2005,20(3):939-944.
  • 6Friedman SL.Mechanisms of disease:Mechanisms of hepatic fibrosis and therapeutic implications.Nat Clin Pract Gastroenterol Hepatol,2004,1(2):98-105.
  • 7Tsukada S,Parsons CJ,Rippe RA.Mechanisms of liver fibrosis.Clin Chim Acta,2006,364(1):33-60.
  • 8Gressner AM,Weiskirchen R,Breitkopf K,et al.Roles of TGF-beta 1 in hepaticfibrosis.Front Biosci,2002,7(4):793-807.
  • 9Sanderson N,Factor V,Nagy J,et al.Hepatic expression of mature transforminggrowth factor beta 1 in transgenic mice results in multiple tissue lesions.Proc Natl Acad Sci USA,1995,92(7):2572-2576.
  • 10Kanzler S,Lohse AW,Keff A,et al.TGF-beta l in liver fibrosis:an inducible transgenic mouse model to study liver fibrogenesis.Am J Physiol Gastrointest Liver Physiol,1999,276(4):G1059-G1068.

二级参考文献24

共引文献10

同被引文献35

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部